Page 80 - Read Online

Cheung et al. Hepatorenal syndrome before liver transplantation

and TIPS in selected patients with cirrhosis and type 1 hepatorenal 39. Chok KS, Fung JY, Chan SC, Cheung TT, Sharr WW, Chan AC,
syndrome. Hepatology 2004;40:55-64. Fan ST, Lo CM. Outcomes of living donor liver transplantation for
34. Martin-Llahi M, Guevara M, Torre A, Fagundes C, Restuccia T, patients with preoperative type 1 hepatorenal syndrome and acute
Gilabert R, Sola E, Pereira G, Marinelli M, Pavesi M, Fernandez hepatic decompensation. Liver Transpl 2012;18:779-85.
J, Rodes J, Arroyo V, Gines P. Prognostic importance of the 40. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF,
cause of renal failure in patients with cirrhosis. Gastroenterology Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver
2011;140:488-96.e4. transplantation (OLTX) using calcineurin-based immunotherapy: risk
35. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, of development and treatment. Transplantation 2001;72:1934-9.
Klammt S, Peszynski P, Freytag J, Hickstein H, Lohr M, Liebe S, 41. Lee JP, Heo NJ, Joo KW, Yi NJ, Suh KS, Moon KC, Kim SG, Kim YS.
Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling Risk factors for consequent kidney impairment and differential impact
system (MARS): clinical results of a new membrane-based blood of liver transplantation on renal function. Nephrol Dial Transplant
purification system for bioartificial liver support. Artif Organs 2010;25:2772-85.
1999;23:319-30. 42. Wong F, Leung W, Al Beshir M, Marquez M, Renner EL. Outcomes of
36. Rahman TM, Hodgson HJ. Review article: liver support systems in patients with cirrhosis and hepatorenal syndrome type 1 treated with
acute hepatic failure. Aliment Pharmacol Ther 1999;13:1255-72. liver transplantation. Liver Transpl 2015;21:300-7.
37. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, 43. Restuccia T, Ortega R, Guevara M, Gines P, Alessandria C, Ozdogan
Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, O, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Rodes J.
Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of Effects of treatment of hepatorenal syndrome before transplantation
hepatorenal syndrome with extracorporeal albumin dialysis MARS: on posttransplantation outcome. A case-control study. J Hepatol
results of a prospective, randomized, controlled clinical trial. Liver 2004;40:140-6.
Transpl 2000;6:277-86. 44. Fayed N, Refaat EK, Yassein TE, Alwaraqy M. Effect of perioperative
38. Arroyo V. New treatments for hepatorenal syndrome. Liver Transpl terlipressin infusion on systemic, hepatic, and renal hemodynamics
2000;6:287-9. during living donor liver transplantation. J Crit Care 2013;28:775-82.

72 Hepatoma Research ¦ Volume 3 ¦ April 12, 2017